Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov 1;13(21):6587.
doi: 10.3390/jcm13216587.

Hemoperfusion with CytoSorb® in Pediatric Patients: A Monocentric Case Series

Affiliations

Hemoperfusion with CytoSorb® in Pediatric Patients: A Monocentric Case Series

Eva Rihar et al. J Clin Med. .

Abstract

Background: Pro- and anti-inflammatory cytokines help regulate the inflammatory response. A cytokine storm is a dysregulated cytokine response associated with sepsis and other conditions that result in a hyper-inflammatory state. Extracorporeal cytokine adsorption has the potential to restore a balanced inflammatory response. Hemoperfusion with CytoSorb® (CS) appears to be a short-term mode of treatment of sepsis in both adults and children. Objective: We present a case series of eight critically ill children involving the use of hemoperfusion with CS at the University Medical Center Ljubljana to treat clinically manifested cytokine storm. Results: In our preliminary experience, it was applied without complication in five children weighing more than 10 kg, who all survived. The effect of age on complications regarding CS treatment is unclear, yet in our case series, all three patients weighing less than 10 kg died of their disease. Conclusions: In our preliminary experience, cytokine adsorption with CS remains a potential adjunctive treatment for cytokine storm in critically ill children.

Keywords: CytoSorb; child; cytokine storm; hemoadsorption; hemoperfusion; neonate; sepsis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

References

    1. Bonavia A., Groff A., Karamchandani K., Singbartl K. Clinical Utility of Extracorporeal Cytokine Hemoadsorption Therapy: A Literature Review. Blood Purif. 2018;46:337–349. doi: 10.1159/000492379. - DOI - PubMed
    1. Ankawi G., Fan W., Pomare Montin D., Lorenzin A., Neri M., Caprara C., de Cal M., Ronco C. A New Series of Sorbent Devices for Multiple Clinical Purposes: Current Evidence and Future Directions. Blood Purif. 2019;47:94–100. doi: 10.1159/000493523. - DOI - PubMed
    1. Rimmele T., Kellum J.A. Clinical review: Blood purification for sepsis. Crit. Care. 2011;15:205. doi: 10.1186/cc9411. - DOI - PMC - PubMed
    1. Jarczak D., Nierhaus A. Cytokine Storm—Definition, Causes, and Implications. Int. J. Mol. Sci. 2022;23:11740. doi: 10.3390/ijms231911740. - DOI - PMC - PubMed
    1. Nakamori Y., Park E.J., Shimaoka M. Immune Deregulation in Sepsis and Septic Shock: Reversing Immune Paralysis by Targeting PD-1/PD-L1 Pathway. Front. Immunol. 2020;11:624279. doi: 10.3389/fimmu.2020.624279. - DOI - PMC - PubMed

LinkOut - more resources